Search Results 1001-1010 of 16973 for monoclonal antibody

  1. A Study Evaluating the Safety and Effectiveness of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) for Adults Hospitalized with Influenza - Mayo Clinic

    The purpose of this study is to test the safety and effectiveness of an antibody ... monoclonal gammopathy); Presence of any pre-existing illness that, in ...

  2. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing - Mayo Clinic

    any indication, including but not limited to chemotherapy, small molecules, monoclonal antibodies, or radiotherapy (with bone marrow impact) within 2 weeks ...

  3. Home office ergonomics tips - Mayo Clinic News Network

    For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org. Monoclonal antibody treatment can help high-risk ...

  4. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... antibody (including ipilimumab, tremelimumab or any other antibody, or drug specifically targeting T cell co stimulatory or immune checkpoint pathways).

  5. Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    ... monoclonal antibodies), this period must be extended beyond the time during which acute adverse events are known to occur; Radiation therapy (RT): ≥ 2 weeks ...

  6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    Ongoing treatment with other monoclonal antibodies (e.g., infliximab, rituximab), immunomodulators (eg, abatacept, methotrexate, azathioprine, cyclosporine) ...

  7. A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer - Mayo Clinic

    NOTE: If there is a history of prior malignancy, they must not be receiving other specific treatment (cytotoxics, monoclonal antibodies, small molecule ...

  8. A Study of Adults 65 Years or Older to Establish Normal Lymphocyte Subsets and Immunoglobulin Levels - Mayo Clinic

    Current or previous treatment with biologics, monoclonal antibodies, or other immunosuppressive treatment (due to possibility of secondary immunodeficiency).

  9. Study shows drug reduces risk of relapse with neuromyelitis optica - Mayo Clinic News Network

    ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with ...

  10. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    Part 2 (Cohort Expansion): Subjects must have received adequate prior therapy including at a minimum including at a minimum anti-CD20 monoclonal antibody ...